Center for Chronic Disease Outcomes Research, Veterans Affairs Health Care System, Minneapolis, MN, USA.
Sleep Med. 2012 Dec;13(10):1217-25. doi: 10.1016/j.sleep.2012.04.010. Epub 2012 Jun 15.
To test the hypothesis that non-frail older men with poorer sleep at baseline are at increased risk of frailty and death at follow-up.
In this prospective cohort study, subjective (questionnaires) and objective sleep parameters (actigraphy, in-home overnight polysomnography) were measured at baseline in 2505 non-frail men aged ≥67years. Repeat frailty status assessment performed an average of 3.4 years later; vital status assessed every four months. Sleep parameters expressed as dichotomized predictors using clinical cut-points. Status at follow-up exam classified as robust, intermediate (pre-frail) stage, frail, or died in interim.
None of the sleep disturbances were associated with the odds of being intermediate/frail/dead (vs. robust) at follow-up. Poor subjective sleep quality (multivariable odds ratio [MOR] 1.26, 95% CI 1.01-1.58), greater nighttime wakefulness (MOR 1.31, 95% CI 1.04-1.66), and greater nocturnal hypoxemia (MOR 1.47, 95% CI 1.02-2.10) were associated with a higher odds of frailty/death at follow-up (vs. robust/intermediate). Excessive daytime sleepiness (MOR 1.60, 95% CI 1.03-2.47), greater nighttime wakefulness (MOR 1.57, 95% CI 1.12-2.20), severe sleep apnea (MOR 1.74, 95% CI 1.04-2.89), and nocturnal hypoxemia (MOR 2.28, 95% CI 1.45-3.58) were associated with higher odds of death (vs. robust/intermediate/frail at follow-up). The association between poor sleep efficiency and mortality nearly reached significance (MOR 1.48, 95% CI 0.99-2.22). Short sleep duration and prolonged sleep latency were not associated with frailty/death or death at follow-up.
Among non-frail older men, poor subjective sleep quality, greater nighttime wakefulness, and greater nocturnal hypoxemia were independently associated with higher odds of frailty or death at follow-up, while excessive daytime sleepiness, greater nighttime wakefulness, severe sleep apnea and greater nocturnal hypoxemia were independently associated with an increased risk of mortality.
验证以下假设,即基线时睡眠较差的非虚弱老年男性在随访时发生虚弱和死亡的风险增加。
在这项前瞻性队列研究中,对 2505 名年龄≥67 岁的非虚弱男性进行了基线时的主观(问卷)和客观睡眠参数(活动记录仪,家庭夜间多导睡眠图)测量。平均在 3.4 年后进行重复虚弱状态评估;每四个月评估一次生存状态。睡眠参数使用临床切点表示为二分类预测因子。随访检查时的状态分类为稳健、中间(衰弱前期)阶段、虚弱或中途死亡。
没有一种睡眠障碍与随访时处于中间/虚弱/死亡(与稳健相比)的几率相关。主观睡眠质量差(多变量比值比 [MOR] 1.26,95%置信区间 [CI] 1.01-1.58)、夜间清醒度增加(MOR 1.31,95% CI 1.04-1.66)和夜间低氧血症加重(MOR 1.47,95% CI 1.02-2.10)与随访时发生衰弱/死亡的几率较高(与稳健/中间相比)相关。白天过度嗜睡(MOR 1.60,95% CI 1.03-2.47)、夜间清醒度增加(MOR 1.57,95% CI 1.12-2.20)、严重睡眠呼吸暂停(MOR 1.74,95% CI 1.04-2.89)和夜间低氧血症(MOR 2.28,95% CI 1.45-3.58)与随访时死亡的几率较高(与稳健/中间/虚弱相比)相关。睡眠效率差与死亡率之间的关联接近显著(MOR 1.48,95% CI 0.99-2.22)。短睡眠时间和长潜伏期睡眠与随访时的虚弱/死亡或死亡无关。
在非虚弱的老年男性中,主观睡眠质量差、夜间清醒度增加和夜间低氧血症与随访时发生虚弱或死亡的几率增加独立相关,而白天过度嗜睡、夜间清醒度增加、严重睡眠呼吸暂停和夜间低氧血症与死亡率增加独立相关。